OpenFilings

Jazz Pharmaceuticals plc

Form10-K

Report Period2023-12-31

Date Filed2024-02-28

Time Filed17:03:44

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
DESCRIPTION OF SHARE CAPITAL
OFFER LETTER
EQUITY AWARD LETTER
AMENDED AND RESTATED 2011 EQUITY INCENTIVE PLAN
AMENDED AND RESTATED GW PHARMACEUTICALS PLC 2020 LONG-TERM INCENTIVE PLAN
AMENDED AND RESTATED 2007 EMPLOYEE STOCK PURCHASE PLAN
LIST OF SUBSIDIARIES
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
CERTIFICATION OF INTERIM PFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
CERTIFICATIONS OF CEO AND INTERIM PFO PURSUANT TO 18 U.S.C. SECTION 1350
INCENTIVE COMPENSATION RECOUPMENT POLICY
Filing on SEC Edgar